Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted...
3 KB (151 words) - 13:19, 24 October 2023
Clinical Therapeutics Current Drug Delivery Current Drug Metabolism Current Opinion in Pharmacology Current Pharmaceutical Design Current Trends in Biotechnology...
4 KB (383 words) - 22:36, 25 September 2024
pentadecapeptide BPC 157: novel therapy in gastrointestinal tract". Current Pharmaceutical Design. 17 (16): 1612–32. doi:10.2174/138161211796196954. PMID 21548867...
5 KB (543 words) - 13:09, 4 September 2024
of advanced glycation end products in diabetic neuropathy". Current Pharmaceutical Design. 14 (10): 953–61. doi:10.2174/138161208784139774. PMID 18473845...
82 KB (9,467 words) - 01:03, 25 September 2024
reductase: biochemical characterization and medical significance". Current Pharmaceutical Design. 19 (14): 2574–93. doi:10.2174/1381612811319140008. PMID 23116396...
34 KB (3,737 words) - 07:12, 15 April 2024
Enzyme inhibitor (section Discovery and design)
McGuire JJ (2003). "Anticancer antifolates: current status and future directions". Current Pharmaceutical Design. 9 (31): 2593–2613. doi:10.2174/1381612033453712...
104 KB (11,579 words) - 19:29, 18 September 2024
prediction of protein targets for structure-based drug design". Current Pharmaceutical Design. 19 (12): 2326–2333. doi:10.2174/1381612811319120019. PMID 23082974...
44 KB (5,022 words) - 20:19, 7 September 2024
effect of cannabis on perception of time: a critical review". Current Pharmaceutical Design. 18 (32): 4915–22. doi:10.2174/138161212802884852. PMID 22716134...
85 KB (10,038 words) - 19:48, 12 September 2024
peptide in neurodevelopmental disorders: therapeutic potential". Current Pharmaceutical Design. 13 (11): 1079–89. doi:10.2174/138161207780618975. PMID 17430171...
23 KB (2,720 words) - 21:13, 18 May 2024
horses of conventional lin- stem/progenitor cell isolates". Current Pharmaceutical Design. 17 (34): 3753–71. doi:10.2174/138161211798357881. PMID 22103846...
15 KB (1,583 words) - 12:51, 22 June 2024
"The Antioxidants and Pro-Antioxidants Network: an Overview". Current Pharmaceutical Design. 10 (14): 1677–94. doi:10.2174/1381612043384655. PMID 15134565...
94 KB (10,236 words) - 01:59, 17 September 2024
"Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents". Current Pharmaceutical Design. 11 (13): 1695–717. doi:10.2174/1381612053764724...
25 KB (2,417 words) - 22:34, 8 August 2024
"Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs". Current Pharmaceutical Design...
32 KB (3,198 words) - 05:07, 17 August 2024
Breakthrough of Heme Oxygenase-1 / Carbon Monoxide Therapeutics?". Current Pharmaceutical Design. 24 (20): 2264–2282. doi:10.2174/1381612824666180723161811....
34 KB (3,774 words) - 05:36, 22 August 2024
"Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs". Current Pharmaceutical Design...
15 KB (1,515 words) - 09:43, 27 September 2024
(2014). "Mitochondrial biogenesis: pharmacological approaches". Current Pharmaceutical Design. 20 (35): 5507–5509. doi:10.2174/138161282035140911142118. hdl:10454/13341...
166 KB (18,358 words) - 23:39, 24 August 2024
Selimoglu, Erol (2007). "Aminoglycoside-induced ototoxicity". Current Pharmaceutical Design. 13 (1): 119–126. doi:10.2174/138161207779313731. PMID 17266591...
24 KB (2,582 words) - 14:38, 15 July 2024
of dietary fiber and short-chain fatty acids in the colon". Current Pharmaceutical Design (Review). 9 (4): 347–58. doi:10.2174/1381612033391973. PMID 12570825...
29 KB (3,263 words) - 02:03, 17 September 2024
Parkinson's disease: state of the art and future directions". Current Pharmaceutical Design. 14 (15): 1475–89. doi:10.2174/138161208784480072. PMID 18537671...
46 KB (5,133 words) - 08:40, 23 September 2024
interest of adenosine A2A receptors in psychiatric disorders". Current Pharmaceutical Design. 14 (15): 1512–24. doi:10.2174/138161208784480090. PMC 2423946...
26 KB (2,060 words) - 22:06, 25 September 2024
Issue: Mitochondrial Biogenesis: Pharmacological Approaches)". Current Pharmaceutical Design. 20 (35): 5507–5509. doi:10.2174/138161282035140911142118. hdl:10454/13341...
24 KB (2,583 words) - 15:25, 6 May 2024
Flavin adenine dinucleotide (section Drug design)
flavin cofactors in man: implications in health and disease". Current Pharmaceutical Design. 19 (14): 2649–75. doi:10.2174/1381612811319140014. PMID 23116402...
39 KB (4,310 words) - 14:35, 24 September 2024
indoor tanning as a behavioral addiction: a literature review". Current Pharmaceutical Design. 20 (25): 4070–4075. doi:10.2174/13816128113199990615. ISSN 1873-4286...
18 KB (1,970 words) - 02:18, 1 September 2024
"Developmental and pathogenic mechanisms of basement membrane assembly". Current Pharmaceutical Design. 15 (12): 1277–94. doi:10.2174/138161209787846766. PMC 2978668...
31 KB (3,430 words) - 21:00, 5 September 2024
non-pharmacological treatment options of major depression". Current Pharmaceutical Design. 12 (4): 503–515. doi:10.2174/138161206775474422. PMID 16472142...
186 KB (20,305 words) - 20:13, 27 September 2024
(2012). "Hyperglycemia and Perioperative Glucose Management". Current Pharmaceutical Design. 18 (38): 6195–6203. doi:10.2174/138161212803832236. PMC 3641560...
38 KB (4,224 words) - 21:55, 6 September 2024
effect of cannabis on perception of time: a critical review". Current Pharmaceutical Design. 18 (32): 4915–4922. doi:10.2174/138161212802884852. ISSN 1873-4286...
9 KB (932 words) - 21:08, 20 April 2023
pharmacokinetic profile, and clinical results in depression". Current Pharmaceutical Design. 11 (12): 1475–93. doi:10.2174/1381612053764805. PMID 15892657...
71 KB (7,047 words) - 01:50, 1 September 2024
Drug Delivery Strategies to Overcome the Blood Brain Barrier". Current Pharmaceutical Design. 22 (9): 1177–1193. doi:10.2174/1381612822666151221150733. PMC 4900538...
39 KB (4,361 words) - 19:02, 24 September 2024
(2003). "Antibiotic prophylaxis in urologic prosthetic surgery". Current Pharmaceutical Design. 9 (12): 989–96. doi:10.2174/1381612033455198. PMID 12678865...
29 KB (3,083 words) - 21:56, 24 September 2024